AFYREN, a French greentech company offering manufacturers biobased, low-carbon ingredients through a unique fermentation technology based on a circular model, received €7 million in additional financing for its subsidiary AFYREN NEOXY. This was obtained through the release of the second tranche of the Sustainability-linked loan secured in December 2024 and the New Industry Loan obtained in November 2024. AFYREN reports a cash position of approximately €35 million as of year-end 2025.
Nicolas Sordet, Chief Executive Officer of AFYREN, stated: “The ramp-up period is a key stage in any industrialization process: it requires mobilizing significant resources for an asset that has not yet reached full capacity. It is therefore crucial to anticipate and secure the necessary financing to navigate this phase with confidence. To achieve this, we rely on a balanced mix of grants, debt, and equity, ensuring the strength of our financial structure. This announcement is also an opportunity to reaffirm our appreciation for our financial partners —banks, institutional partners, institutions providing innovation funding, and shareholders— who have supported us since our inception.”
In December 2024, AFYREN secured a €10 million Sustainability-linked loan to support the start-up and ramp-up of the AFYREN NEOXY plant, with €6 million disbursed immediately. AFYREN is now announcing the release of the additional €4 million tranche and the renewed support of the banking syndicate comprising long-term partners BNP Paribas and Banque Populaire Auvergne Rhône-Alpes, plus new partners Société Générale, Caisse d’ Épargne et de Prévoyance Rhône-Alpes and LCL.
As with the first tranche, this financing will link the cost of credit to AFYREN’s ESG performance, particularly in the social dimension, ESG rating, and then the company’s environmental impact—a pioneering approach for a young industrial company.
IL BIOECONOMISTA 